Arthur Fischbach (@ArthurFischbach) profile picture

Researcher trying to understand and unpuzzle the aging process

Germany
Joined February 2011
Photo by Arthur Fischbach (@ArthurFischbach)Photo by Arthur Fischbach (@ArthurFischbach)
I have built CitationTool: an agent skill to reduce hallucinated sources in LLM-assisted scientific writing. It verifies DOI/PMID, checks whether abstracts support cited claims, and creates Word files with real Zotero-editable citations + bibliography. github.com/fischbacha/Citati…
🤖 Made with AI
2
1
75
Arthur Fischbach retweeted
Our new paper, “Simply Aging,” is out in @PNASNews! What is aging, when does it begin, how do we measure it, and what would it take to extend lifespan? We tackle these questions directly and simply. 📄 Read: pnas.org/doi/10.1073/pnas.26… 💬 Discuss: simplyaging.xyz/
7
52
7
224
24,064
Arthur Fischbach retweeted
Wir verlosen eine NVIDIA GeForce RTX 5090 im individuellen Hogwarts Legacy-Design, um den offiziellen Release mit DLSS 5 zu feiern 🪄 So machst du mit: 🟢 Teile diesen Beitrag 🟢 Kommentiere mit #RTXON
23,076
20,897
1,239
21,609
1,994,023
Arthur Fischbach retweeted
One PhD position is available in my lab as part of the consortium TRR/CRC 440 "smART - specific mRNA targeting". The project aims to generate a small molecule toolkit to study the biological role of the mtDNA-encoded 7S RNA. Link: stellenangebote.uni-marburg.…
10
18
859
Arthur Fischbach retweeted
The full story of our paper, in one thread. Super grateful to everyone who carried this! #Celegans #Splicing #Metabolism #VitaminB12 #Phospholipids #RareDisease @NatureComms @NaturePortfolio
1/8 🚨 Out now in @NatureComms 🚨 A vitamin mitigates symptoms of a rare genetic disease. Verheij syndrome is caused by mutations in the mRNA splicing factor PUF60. Vitamin B12 restores normal development in our disease model, the worm C. elegans. rdcu.be/fyIgM
2
2
220
Arthur Fischbach retweeted
Claude Science is incredible. I gave it some sequencing data, and in 8 hours it did a full analysis, generated figures, wrote a paper, submitted it for publication, got rejected, revised and resubmitted, got rejected again, it is now applying for positions in industry
102
663
59
9,009
498,962
It works with Claude Code, Codex and Opencode
34
6/ The bibliography can be edited with the Zotero Word plugin. You can click the citation, refresh the bibliography, add references, change citation styles, and continue working in the normal Word/Zotero workflow.
1
14
Start by telling your agent: Install and use the CitationTool skill from github.com/fischbacha/Citati…. I want a Zotero-active Word draft with verified references.
15
Arthur Fischbach retweeted
Out of all the announcements at @Google I/O today, this is the one closest to my heart - our foundational research on Co-Scientist was published in @Nature and we announced its broad availability via @GeminiApp for Science. When you are suffering from a disease, time is everything. As our collaborator and @StanfordMed Professor Dr. Gary Peltz reminds us, there are thousands of diseases out there with zero treatments. There is simply so much left to solve. Our goal with Co-Scientist has been to give scientists superpowers and help them get to these answers faster - compressing the scientific process from months and years down to hours and days. Much like Galileo's telescope helped us look into the stars, Co-Scientist is designed to help us make sense of the vast complexity of biological and scientific data. It is among the first examples of a truly general-purpose multi-agent system for scientific discovery. The core research question behind it was: How can an AI system engage in the rigorous, structured thinking that’s the hallmark of science and scientists? To tackle this, Co-Scientist builds on the principles of self-play and self-improvement underpinning @GoogleDeepMind breakthroughs like AlphaGo, generalizing them to scientific reasoning through self-debates. Since our preprint last year, we have further improved its capabilities and have been validating it in collaborations with scientists across over 100 institutions globally, spanning both academia and industry. And we are thrilled to see the emergence of a new form of AI-human scientist collaboration that's already leading to important new insights, discoveries and peer reviewed publications - from understanding antimicrobial resistance (published in @CellCellPress) to decoding plant immunity, to identifying new treatments for liver fibrosis (Advanced Science), cancer, neurodegenerative diseases like ALS and the grand challenge of aging. I have always believed AI's greatest promise is accelerating scientific discovery and advancing human health. My genuine hope for the future is that AI tools like Co-Scientist help democratize science, giving anyone, anywhere the means to pursue their child-like curiosity and change the world. This work was done with stellar team mates spanning @GoogleDeepMind @GoogleResearch, @googlecloud and @GoogleLabs especially Juro Gottweis (@Mysiak ), who is the heart and soul of this effort. Special thanks also to all our wonderful collaborators: Gary Peltz, @CostaT_Lab, @jrpenades, @_e_d_v_ , @iambyronic, @OpsBug, @jgooten, @omarabudayyeh Ritu Raman, Ryan Flynn, Filippo Menolascina, Velia Siciliano, Clare Bryant, Matt Onsum, Katherine Labbé and more. Nature paper link - lnkd.in/e8qBEJFv Google DeepMind blog - lnkd.in/etYeahMy Gemini for Science - labs.google/science.
20
113
13
535
86,095
Arthur Fischbach retweeted
I’m incredibly proud of The AI Scientist team for this milestone publication in @Nature. We started this project to explore if foundation models could execute the entire research lifecycle. Seeing this work validated at this level is a special moment. I truly believe AI will forever change the landscape of how scientific discoveries and scientific progress are made.
The AI Scientist: Towards Fully Automated AI Research, Now Published in Nature Nature: nature.com/articles/s41586-0… Blog: sakana.ai/ai-scientist-natur… When we first introduced The AI Scientist, we shared an ambitious vision of an agent powered by foundation models capable of executing the entire machine learning research lifecycle. From inventing ideas and writing code to executing experiments and drafting the manuscript, the system demonstrated that end-to-end automation of the scientific process is possible. Soon after, we shared a historic update: the improved AI Scientist-v2 produced the first fully AI-generated paper to pass a rigorous human peer-review process. Today, we are happy to announce that “The AI Scientist: Towards Fully Automated AI Research,” our paper describing all of this work, along with fresh new insights, has been published in @Nature! This Nature publication consolidates these milestones and details the underlying foundation model orchestration. It also introduces our Automated Reviewer, which matches human review judgments and actually exceeds standard inter-human agreement. Crucially, by using this reviewer to grade papers generated by different foundation models, we discovered a clear scaling law of science. As the underlying foundation models improve, the quality of the generated scientific papers increases correspondingly. This implies that as compute costs decrease and model capabilities continue to exponentially increase, future versions of The AI Scientist will be substantially more capable. Building upon our previous open-source releases (github.com/SakanaAI/AI-Scien…), this open-access Nature publication comprehensively details our system's architecture, outlines several new scaling results, and discusses the promise and challenges of AI-generated science. This substantial milestone is the result of a close and fruitful collaboration between researchers at Sakana AI, the University of British Columbia (UBC) and the Vector Institute, and the University of Oxford. Congrats to the team! @_chris_lu_ @cong_ml @RobertTLange @_yutaroyamada @shengranhu @j_foerst @hardmaru @jeffclune
93
154
9
1,239
295,651
Excited to share our new paper on the biochemistry of poly(ADP-ribosyl)ation, a post-translational modification central to the cellular response to genotoxic stress, aging and an established target in cancer treatment. pubs.acs.org/doi/10.1021/acs…
1
25
Here we studied how diverse protein modules target proteins for covalent poly(ADP-ribosyl)ation. This research may inform future therapeutic strategies aimed at modulating PAR signaling in disease. Thank you to all co-authors Klara Bangert, Alexander Bürkle and Aswin Mangerich!
10
Arthur Fischbach retweeted
At @GoogleDeepMind, we believe AI is the ultimate catalyst for science. 🧬 The best example of this has been the AlphaFold database (AFDB) of protein structure predictions which has been used free of cost by more than 3.3 millions researchers across the world! Today, in collaboration with @emblebi, @Nvidia and @SeoulNatlUni, we are expanding the database by adding millions of AI-predicted protein complex structures to the AlphaFold Database. To maximise global health impact, we’ve prioritised proteins that are important for understanding human health and disease, including homodimers from 20 of the most studied organisms, including humans, as well as the @WHO’S bacterial priority pathogens list. Read more here: embl.org/news/science-techno…
86
391
28
2,457
165,330
Arthur Fischbach retweeted
Cool use case of AlphaFold, this is just the beginning of digital biology!
this is actually insane > be tech guy in australia > adopt cancer riddled rescue dog, months to live > not_going_to_give_you_up.mp4 > pay $3,000 to sequence her tumor DNA > feed it to ChatGPT and AlphaFold > zero background in biology > identify mutated proteins, match them to drug targets > design a custom mRNA cancer vaccine from scratch > genomics professor is “gobsmacked” that some puppy lover did this on his own > need ethics approval to administer it > red tape takes longer than designing the vaccine > 3 months, finally approved > drive 10 hours to get rosie her first injection > tumor halves > coat gets glossy again > dog is alive and happy > professor: “if we can do this for a dog, why aren’t we rolling this out to humans?” one man with a chatbot, and $3,000 just outperformed the entire pharmaceutical discovery pipeline. we are going to cure so many diseases. I dont think people realize how good things are going to get
187
738
89
7,307
833,035